Robert S. Mills - 03 Jul 2024 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 03 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2024, 17:44:15 UTC
Prior SEC filing: 22 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Robert S. Mills, by Kirk Allen Coleman, as Attorney-in-Fact

Key filing fact

Robert S. Mills filed Form 4 for TFF Pharmaceuticals, Inc. on 08 Jul 2024.

Key facts

This page summarizes Robert S. Mills's Form 4 filing for TFF Pharmaceuticals, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jul 2024, 17:44.

Change

Previous filing in this sequence was filed on 22 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TFFP transaction

Common Stock

Award

Transaction value: $0
Shares: +3,165
Change %: +5.7%
Price: $0.000000
Shares after: 59,145
Date: 03 Jul 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TFFP transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +3,165
Change %
Price: $0.000000
Shares after: 3,165
Date: 03 Jul 2024
Ownership: Direct
Underlying class: Common stock
Underlying amount: 3,165
Exercise price: $1.82
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in full on June 19, 2025.

Footnote F2

Options vest in full on June 19, 2025.